Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

What’s in the EU-UK Brexit Deal?

After long months of negotiations, the EU and UK have a Brexit…
Read more

Iran to Move Forward With Uranium Enrichment

Iran has said it plans to increase uranium enrichment up…
Read more

‘USS Nimitz’ Turns Around

After beginning its way toward the Middle East, a US aircraft…
Read more